ACS Survey: Chemistry Salary Increases Sink To Lowest Point In 10-Year Period

Some chemists getting ready to attend the spring meeting of the American Chemical Society (ACS), to take place in Anaheim, Calif., April 2-6, undoubtedly are preoccupied by personal concerns: According to a recently released ACS survey, salary increases for those working in the field during the 12-month period that ended March 1, 1994, were the lowest in a decade. And those in a position to receive these meager pay raises are the lucky ones--in the year studied, the survey found, chemistry unem

Written byEdward Silverman
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Some chemists getting ready to attend the spring meeting of the American Chemical Society (ACS), to take place in Anaheim, Calif., April 2-6, undoubtedly are preoccupied by personal concerns: According to a recently released ACS survey, salary increases for those working in the field during the 12-month period that ended March 1, 1994, were the lowest in a decade. And those in a position to receive these meager pay raises are the lucky ones--in the year studied, the survey found, chemistry unemployment reached a 22-year high.

The findings underscore that "there's still a lot of trimming going on in the chemical industry, and it's just starting to hit the pharmaceutical industry," says Corinne Marasco, a senior research associate at ACS.

"The basic chemical companies have been hurt by worldwide overcapacity. It's a mature industry, and there's no longer the tremendous growth associated with the postwar period. And so there's less ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies